In this episode of The Scalpel’s Edge, Dr. Tim Sayed takes a deep dive into the latest research on GLP1 medications and the lesser known side effects patients may experience. Drawing from new studies, clinical insights, and his own experience with GLP1 therapy, Dr. Sayed breaks down how these medications may influence anemia risk, micronutrient deficiencies, appetite changes, and overall metabolic health.

He also explores new data on hemoglobin changes, iron intake, B12 levels, and nutritional patterns seen in GLP1 users. Dr. Sayed reviews current guidance for assessing risk, monitoring labs, and supporting patients through evidence-informed nutritional strategies. The episode closes with an important discussion on tapering and discontinuation, highlighting why there is still no standardized exit plan and how physicians can work with patients to navigate the evolving landscape of GLP1 treatment.

Tune in for a grounded, practical, and insightful conversation on optimizing health while using GLP1s.

Contact Dr. Tim Sayed:
Phone: (858) 247-2933
Email: [email protected]
Website: timsayedmd.com
Instagram: @timsayedmd
YouTube: @Timsayedmd
Facebook: Tim Sayed MD